Results: 123

Discovery of the ARP2 protein as a determining molecule in tumor cell death

Gac. méd. Méx; 155 (5), 2019
Cancer is a multifactorial disease that constitutes a serious public health problem worldwide. Prostate cancer advanced stages are associated with the development of androgen-independent tumors and an apoptosis-resistant phenotype that progresses to metastasis. By studying androgen-independent lymphoid n...

Expression of stromal elements of prostatic adenocarcinoma in different gleason scores

Acta cir. bras; 34 (10), 2019
Abstract Purpose: To quantify and compare the expression of stromal elements in prostate adenocarcinoma of different Gleason scores with non-tumor area (control). Methods: We obtained 132 specimens from samples of prostate peripheral and transition zone. We analyzed the following elements of the extrac...

Associação de variáveis sociodemográficas e clínicas com os tempos para início do tratamento do câncer de próstata

Resumo Disparidades na atenção ao câncer de próstata têm sido reveladas e associadas a fatores sociodemográficos e clínicos, os quais determinam os tempos para diagnóstico e início do tratamento. O objetivo deste artigo é avaliar a associação de variáveis sociodemográficas e clínicas com o...

Biological roles of filamin a in prostate cancer cells

Int. braz. j. urol; 45 (5), 2019
ABSTRACT Objective This study aims to investigate the association of filamin A with the function and morphology of prostate cancer (PCa) cells, and explore the role of filamin A in the development of PCa, in order to analyze its significance in the evolvement of PCa. Materials and Methods A stably tr...

Is possible to rule out clinically significant prostate cancer using PI-RADS v2 for the assessment of prostate MRI?

Int. braz. j. urol; 45 (4), 2019
ABSTRACT Objectives To evaluate the diagnostic performance and interobserver agreement of PI-RADS v2. Materials and Methods In this Institutional Review Board approved single-center retrospective study, 98 patients with clinically suspected PCa who underwent 3-T multiparametric MRI followed by MRI/TR...

A comparison of perioperative outcome between robot-assisted and laparoscopic radical prostatectomy: experience of a single institution

Int. braz. j. urol; 45 (4), 2019
ABSTRACT Purpose To compare perioperative and pathological results in different approaches of robotic or laparoscopic radical prostatectomy. Materials and Methods We retrospectively reviewed 206 patients diagnosed with prostate cancer (PC) from June 2016 to October 2017 in the First Affiliated Hospit...

Detection of clinically significant prostate cancer with PI-RADS v2 scores, PSA density, and ADC values in regions with and without mpMRI visible lesions

Int. braz. j. urol; 45 (4), 2019
ABSTRACT Purpose To determine if PSAD, PSADtz, and ADC values improve the accuracy of PI-RADS v2 and identify men whose concurrent systematic biopsy detects clinically significant cancer on areas without mpMRI visible lesions. Materials and methods Single reference-center, cross-sectional, retrospecti...

Re: The role of 68Ga-PSMA-PET/CT in radiotherapy planning in prostate cancer

Int. braz. j. urol; 45 (4), 2019

Debut de adenocarcinoma de próstata en adenopatía cervical metastásica: reporte de caso clínico

Rev. méd. Maule; 34 (1), 2019
INTRODUCTION: Prostatic carcinoma is a tumor that occurs mainly in men older than 50 years. More than 95% correspond to adenocarcinomas and their degree of tumor differentiation is related to metastasis and death. Becausemetastasis to cervical lymphatics is infrequent and with worse survival, a clinical ...

Densidad del antígeno prostático en el diagnóstico de cáncer de próstata
Prostate antigen density in the diagnosis of prostate cancer

El cáncer de próstata es un problema de salud pública a nivel mundial, el cual clásicamente se sospecha por alteració en el antígeno prostático (PSA) y/o tacto rectal (TR) y se confirma con biopsia prostática. No obstante, existen otros marcadores como la densidad del PSA (DPSA) que se emplean pa...